Refsum's disease (MIM 266500) is a recessive disorder characterised by defective peroxisomal alpha-oxidation of phytanic acid. A Refsum's disease gene, phytanoyl-CoA hydroxylase (PAHX), has been localised to chromosome 10p13 between the markers D10S226-D10S223. This study investigated whether all cases of Refsum's disease were linked with chromosome 10p13. Eight genetically informative families comprising 92 individuals including 17 living patients with a Refsum's disease phenotype and initial plasma phytanic acid > 200 µmol/L were recruited. Linkage to the 10pter-10p11.2 region was investigated using a panel of eight dinucleotide repeat markers. Linkage analysis of this phenotypically identical cohort suggested that Refsum's disease was genetically heterogeneous (Z max = 5.28, α = 0.45). Two subgroups were identified. One group of four families with eight affected individuals had a maximum multipoint lod score for linkage of 3.89 in the region D10S547 to D10S191, whilst in another three families with nine affected individuals linkage to this region was definitely excluded. Our results show that Refsum's disease is genetically heterogeneous, with up to 55% of cases not being linked to the PAHX gene locus at D10S547 to D10S223. This suggests that Refsum's disease, in common with other peroxisomal 'diseases', may be more accurately described as a heterogeneous syndrome.
Introduction
Refsum's disease (MIM 266500) is an autosomal recessive disorder characterised by defective peroxisomal alpha-oxidation of phytanic acid leading to presentation in adolescence with retinitis pigmentosa which progresses to eventual blindness. Other features with variable penetrance include anosmia, deafness, sensory neuropathy, ichthyosis, ataxia, peripheral skeletal or limb dysmorphology and cardiomyopathy. 1 A Refsum's disease gene, phytanoyl-CoA hydroxylase (PAHX), has been localised to chromosome 10p13 between the markers D10S226-D10S4223 near D10S191. 2, 3 Mutations in PAHX have been identified in 13 cases of Refsum's disease. 4 This study investigated whether all cases of Refsum's disease were linked with chromosome 10p13. 
Materials and methods

Results
Statistical analysis of the two point linkage data for the families is shown in Table 1 . Initial analysis revealed no linkage of Refsum's disease in the overall cohort to chromosome 10. Analysis for genetic heterogeneity allowing for admixture was conducted using the program HOMOG giving a result of Z max = 5.284 at a distance (θ) of 0.25 from D10S249, and a proportion of linked families (α) of 0.45. Analysis of the components of 2 gave a value of X 2 = 10.57; P < 0.001 for heterogeneity confirming the presence of significant genetic heterogeneity in this cohort. Data on the conditional probability of linkage by pedigree is shown in Table 1 . In pedigrees 1-4 a maximum multipoint lod score for linkage of 3.89 to the region D10S547 to D10S191 could be obtained by post hoc analysis. Pedigrees and haplotypes of four families not linked to chromosome 10 are shown in Figure 1 . In pedigrees 6-8 definite exclusion of linkage was found for the region D10S547 to D10S191 and D10S197 with multipoint lod scores < -5.
Comparison of the clinical and biochemical features of Refsum's disease phenotype between the two groups of patients revealed no differences in clinical presentation manifest clinical symptoms, severity of disease and initial or post-treatment plasma phytanic acid concentration.
Discussion
Refsum's disease is a peroxisomal disorder associated solely with a deficiency of phytanic acid metabolism and can be caused by mutations in the PAHX gene which has been localised to the region D10S226 to D10S223. [2] [3] [4] All but one case of Refsum's disease described to date have been found to be due to mutations in PAHX linked to these chromosome 10 loci, or not to complement cell lines from patients with Refsum's disease. The atypical case presented with classical features of Refsum's disease, but his fibroblasts complemented fibroblasts from patients with Refsum's disease and not those from patients with rhizomelic chondrodysplasia (RCDP). 7 In our series of 17 cases in the UK, four pedigrees showed evidence of linkage to the region D10S547 to D10S191 where PAHX is located. This is consistent with previous reports and suggests a closer localisation of the PAHX gene between the markers D10S547 and D10S223. However, genetic heterogeneity was present, as 55% of the cohort did not show linkage to this region when evaluated at the best location for the group.
All these patients presented with a classical phenotype and could not be differentiated from the PAHX-linked group by clinical or biochemical criteria. However, the phenotype of Refsum's disease may be misleading as one consanguineous Atypical clinical and biochemical features included leukodystrophy and pipecolic acidaemia which are features of generalised peroxisomal assembly disorders presenting as the continuum between Zellweger's syndrome and infantile Refsum's disease (IRD) but not of the complementation group which includes Refsum's disease. 10 Our results show that Refsum's disease is genetically heterogeneous with 55% of cases likely to be caused by mutations in genes other than PAHX. Taking our results and those of the other atypical cases, the clinical phenotypic and genetic data suggests that the constellation of features termed Refsum's disease are not homogeneous and, in common with other peroxisomal diseases, 10 are more likely to represent a syndrome with multiple causes rather than a monogenic disorder. 
